IOF News

October 21, 2019
Committee for Medicinal Products for Human Use (CHMP) has announced a positive opinion recommending marketing authorization for romosozumab for the treatment of severe osteoporosis in postmenopausal women.
October 20, 2019
World Osteoporosis Day is the occasion to raise public awareness through the media, and to call on health authorities to reduce the costly burden of fragility fractures in their countries.
October 18, 2019
Con motivo del Día Mundial de la Osteoporosis 2019, la IOF emitió este comunicado de prensa mundial a los medios de comunicación de todas las regiones del mundo:
October 18, 2019
For World Osteoporosis Day 2019, IOF issued a global press release to media in all regions of the world, shown below.
October 16, 2019
Find out with the new IOF Osteoporosis Risk Check - soon available in 34 languages
October 16, 2019
IOF thanks the American Association of Clinical Endocrinologists (AACE) for their participation in this year's World Osteoporosis Day campaign, and for their important endorsement of the IOF Global Patient Charter.
September 23, 2019
IOF participó activamente del congreso que reunió alrededor de 500 profesionales médicos en la ciudad de Panamá
September 20, 2019
From promises to progress on Health for All: NCD Alliance and 130 organizations around the world, send Open Letter to Governments ahead of the UN High-Level Meeting on Universal Health Coverage
September 13, 2019
IOF CEO Philippe Halbout recently travelled to four Asian cities to liaise with local member societies, healthcare providers and health authorities, providing a global perspective and support for national efforts to drive change in health care policies.
September 12, 2019
El programa Getting to Gold comienza en México con la fase "Train the Mentor".

Pages